MNMD
$6.55
Mind Medicine Mindmed
($.38)
(5.48%)
MNMD
Earnings Whisper ®
N/A
1st Quarter March 2025
Consensus:  ($0.36)
Revenue:  N/A
Thursday
May 8
7:00 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when MNMD reports earnings?
Beat
Meet
Miss

Where is MNMD's stock price going from here?
Up
Flat
Down
Stock chart of MNMD
Analysts
Summary of analysts' recommendations for MNMD
Score
Grade
Pivots
Resistance
$7.18
$7.04
$6.80

$6.66

Support
$6.42
$6.28
$6.04
Tweet
Growth
Description
Mind Medicine Inc. is a clinical-stage psychedelic medicine biotech company. It discovers, develops and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. Mind Medicine Inc. is based in New York, United States.
›